Pharmaceutical Partners of Canada Recognized for Supporting Medical Relief Missions

matthew rotenberg and michel harpin

L to R: Matthew Rotenberg, General Manager, Pharmaceutical Partners of Canada; Michel Harpin, Executive Director, Industry Relations, HPIC.

May 7, 2013 (MONTREAL) – Health Partners International of Canada (HPIC) congratulates Pharmaceutical Partners of Canada (PPC), a company of the Fresenius Kabi Group, for passing the $10 million milestone in donated medicines for the developing world.

“Since 1998, PPC has been a partner of HPIC, giving medicines specially requested by doctors going on medical missions,” said Glen Shepherd, President of HPIC. “We are very grateful for this essential support of our mission to increase access to medicine for the most vulnerable people in the world.”

In 2012, PPC, was a top donor and is recognized as an HPIC Health Builder. One recent example of PPC’s support of HPIC allowed family physician Dr. Jennifer Wilson of Uxbridge, Ontario to be supplied oxytocin and diphenhydramine for her medical mission to Ghana. Dr. Wilson has been travelling regularly to Ghana for years to provide basic medical care.

Oxytocin was used to prevent mothers from bleeding to death after giving birth, a common cause of maternal mortality.

“That is just one small donation of oxytocin for one doctor,” said Shepherd. “Imagine the effects multiplied over the years PPC has been donating to HPIC. Imagine how many mothers are alive to care for their children and how many children have survived to learn and contribute to their community. On behalf of those we serve, we thank Pharmaceutical Partners of Canada and their employees.”